WebbRETACRIT •safely and effectively. See full prescribing information for RETACRIT. RETACRIT™ (epoetin alfa-epbx) injection, for i ntravenous or subcutaneous use . … WebbEpoetin Alfa (Epogen, Procrit) Drug type : Therapeutic: antianemics Pharmacologic: hormones, erythropoiesis stimulating agents Prototype: Epogen, Eprex, Procrit, Retacrit Indications: Anemia associated with chronic kidney disease (CKD). Anemia secondary to zidovudine (AZT) therapy in HIVinfected patients. Anemia from chemotherapy in …
THIS LIST APPLIES TO ALL COMMERCIAL FULLY-INSURED MEMBERS
Webb3.美国FDA批准一种新的生物仿制药Retacrit (epoetin alfa-epbx)治疗贫血 [J], 夏训明 4.Biosimilar Epoetin Zeta in Nephrology: Effect of Injection Frequency on Weekly Dose [J], Gerhard Lonnemann;Eike Wrenger 抗贫血药 重组人红细胞生成素（Epoetin） 王敏 【期刊名称】《国外医药：合成药．生化药．制剂分册》 【年 (卷),期】1990 (011)004 Webbredness and pain at the Retacrit injection site; These are not all of the possible side effects of Retacrit. Your healthcare provider can give you a more complete list. Tell … 卵 鶏肉 玉ねぎ トマト
RETACRIT™ Dosage and Administration (epoetin alfa-epbx)
WebbMedicare prescription drug plans typically list Retacrit on Tier 4 of their formulary. Generally, the higher the tier, the more you have to pay for the medication. Most plans have 5 tiers. Does your plan have restrictions? See discount prices that can save you money when your Medicare plan doesn't work for you. View Prices WebbClinical Trials. Leaders to Clinical Trials Your take makes a difference ; Clinical Trials in Children Designed to improve kids' health ; Data and Results Participation our Results ; Integrity and Transparency Building Trust ; Diversity Equity the Representation ; Plain Language Study Results Trial Result Summaries WebbAlmost all patients (99.9%) received the biosimilar epoetin zeta (Retacrit). Patients in both groups responded well to treatment with biosimilar epoetin, with 79.8% and 84% responding at 3 months and 86.3% and 86.8% at 6 months among younger and elderly cohorts, respectively. 卵 黒い点 殻 外側